Table 5.
Administration | Enzyme activity (IU/L) | ||||||
---|---|---|---|---|---|---|---|
Day 1 | Day 7 | Day 14 | Day 28 | Day 42 | Day 56 | Day 71 | |
AST | |||||||
Intravenous | 801 ± 255 | 1,390 ± 492 | 644 ± 200 | 281 ± 81 | |||
Intrapleural | 214 ± 65 | 219 ± 38 | 202 ± 30 | 173 ± 23 | 169 ± 31 | ||
ALT | |||||||
Intravenous | 356 ± 112 | 1,881 ± 648 | 1,031 ± 320 | 223 ± 62 | |||
Intrapleural | 361 ± 172 | 180 ± 63 | 205 ± 55 | 76 ± 12 | 65 ± 14 |
Data show average and SE values (n = 5). CrlJ:CD1 mice injected with Ad-NK4 were 5-week old male. Data of untreated CrlJ:CD1 male mice at 11-week old (Japan Charles river, Japan) as follows.
AST, 76 ± 11 IU/l; ALT, 32 ± 7 IU/l.